Meihua International Medical Technologies Co., Ltd.

corporate_fare Company Profile

Meihua International Medical Technologies Co., Ltd.

MHUAF·OTC·Industrial Applications And Services·CIK 0001835615

Meihua is a Cayman Islands holding company that operates its business through its indirect subsidiaries located in mainland China. The company's direct subsidiary is Kang Fu International Medical, a Hong Kong company. Meihua's operations are conducted by its subsidiaries in China, including Yangzhou Huada Medical Device Co., Ltd., or Yangzhou Huada. Yangzhou Huada is a wholly-owned subsidiary of Kang Fu International Medical, established in Yangzhou, Jiangsu Province, PRC on December 24, 2001, with a registered capital of $602,400. Yangzhou Huada manufactures and sells Class I disposable medical devices under its own brands. It also distributes Class I and Class II disposable medical devices sourced from other manufacturers to domestic customers. Specifically, Yangzhou Huada focuses on the manufacturing, sales, and distribution of non-bottled products, such as brushes and ID bracelets, for domestic sales.

Meihua International Medical Technologies Co., Ltd. (OTC:MHUAF) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors MHUAF SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

Meihua International Medical Technologies Appeals Nasdaq Delisting After Panel Denies Reinstatement (2026-03-02)
Selling Shareholders Register 520,000 Shares for Resale, Adding Significant Market Overhang (2026-02-24)
Meihua Waives Lock-Up for Private Placement Investors, Allowing Controlled Resales (2026-02-02)
Meihua International Secures 12-Month Lock-Up on $16.5M Private Placement Shares, Preventing Immediate Selling Pressure (2026-01-23)

Insider Transactions

MHUAF files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with M →

show_chartPrice Chart

Loading chart...

feed MHUAF - Latest Insights

Filing Type

Date Range

MHUAF

Mar 02, 2026, 4:05 PM EST

Filing Type: 6-K

Importance Score:

Meihua International Medical Technologies Appeals Nasdaq Delisting After Panel Denies Reinstatement

Price at Filing: $8.89

Real-time Price: $8.30

Change: -$0.590 (-7%)

Market Cap: $5.793M

Sentiment: Negative

View Wiseek Article

MHUAF

Feb 24, 2026, 4:15 PM EST

Filing Type: F-3

Importance Score:

Selling Shareholders Register 520,000 Shares for Resale, Adding Significant Market Overhang

Price at Filing: $9.43

Real-time Price: $8.30

Change: -$1.13 (-12%)

Market Cap: $5.793M

Sentiment: Negative

View Wiseek Article

MHUAF

Feb 02, 2026, 4:15 PM EST

Filing Type: 6-K

Importance Score:

Meihua Waives Lock-Up for Private Placement Investors, Allowing Controlled Resales

Price at Filing: $11.16

Real-time Price: $8.30

Change: -$2.86 (-26%)

Market Cap: $5.793M

Sentiment: Negative

View Wiseek Article

MHUAF

Jan 22, 2026, 9:38 PM EST

Filing Type: 6-K

Importance Score:

Meihua International Secures 12-Month Lock-Up on $16.5M Private Placement Shares, Preventing Immediate Selling Pressure

Price at Filing: $6.00

Real-time Price: $8.30

Change: +$2.30 (+38%)

Market Cap: $5.793M

Sentiment: Positive

View Wiseek Article

corporate_fare Company Profile